Di Maio, M., Daniele, G., & Piccirillo, M. (2013). Impact on health-related quality of life of the addition of bevacizumab to first-line chemotherapy for ovarian cancer:  . Cancer Breaking News, 1(1), 33–35. Retrieved from https://journals.aboutscience.eu/index.php/cancerbreakingnews/article/view/254